Cargando…
Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942286/ https://www.ncbi.nlm.nih.gov/pubmed/36810121 http://dx.doi.org/10.1186/s12957-023-02931-z |
| _version_ | 1784891465096232960 |
|---|---|
| author | Oner, Gizem Önder, Semen Karatay, Hüseyin Ak, Naziye Tükenmez, Mustafa Müslümanoğlu, Mahmut İğci, Abdullah Dincçağ, Ahmet Özmen, Vahit Aydiner, Adnan Yavuz, Ekrem Cabioğlu, Neslihan |
| author_facet | Oner, Gizem Önder, Semen Karatay, Hüseyin Ak, Naziye Tükenmez, Mustafa Müslümanoğlu, Mahmut İğci, Abdullah Dincçağ, Ahmet Özmen, Vahit Aydiner, Adnan Yavuz, Ekrem Cabioğlu, Neslihan |
| author_sort | Oner, Gizem |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9942286 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99422862023-02-22 Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy Oner, Gizem Önder, Semen Karatay, Hüseyin Ak, Naziye Tükenmez, Mustafa Müslümanoğlu, Mahmut İğci, Abdullah Dincçağ, Ahmet Özmen, Vahit Aydiner, Adnan Yavuz, Ekrem Cabioğlu, Neslihan World J Surg Oncol Correction BioMed Central 2023-02-21 /pmc/articles/PMC9942286/ /pubmed/36810121 http://dx.doi.org/10.1186/s12957-023-02931-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Oner, Gizem Önder, Semen Karatay, Hüseyin Ak, Naziye Tükenmez, Mustafa Müslümanoğlu, Mahmut İğci, Abdullah Dincçağ, Ahmet Özmen, Vahit Aydiner, Adnan Yavuz, Ekrem Cabioğlu, Neslihan Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy |
| title | Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy |
| title_full | Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy |
| title_fullStr | Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy |
| title_full_unstemmed | Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy |
| title_short | Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy |
| title_sort | correction: clinical impact of pd-l1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942286/ https://www.ncbi.nlm.nih.gov/pubmed/36810121 http://dx.doi.org/10.1186/s12957-023-02931-z |
| work_keys_str_mv | AT onergizem correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT ondersemen correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT karatayhuseyin correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT aknaziye correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT tukenmezmustafa correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT muslumanoglumahmut correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT igciabdullah correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT dinccagahmet correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT ozmenvahit correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT aydineradnan correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT yavuzekrem correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT cabiogluneslihan correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy |